Eroglu C, Yildiz E, Ozturk M, Pinarbasi E
Department of Molecular Biology and Genetics, Science Faculty, Bilkent University, Ankara, Turkey.
Acta Virol. 2000 Feb;44(1):29-33.
In this study, a 178 amino acids long portion of the hepatitis C virus (HCV) core gene was cloned, sequenced, expressed in Escherichia coli, and purified. The resulting antigen (C178) was tested with human sera enzyme-linked immunosorbent assay (ELISA) in order to assess its ability to diagnose HCV. It was shown by ELISA that 92% of the patients sera, diagnosed previously by a 3rd generation enzyme immunoassay (EIA) as HCV-positive, had antibodies against the C178 antigen. This antigen gave no false positive results when tested with anti-HCV-negative sera.
在本研究中,克隆、测序了丙型肝炎病毒(HCV)核心基因一段长度为178个氨基酸的片段,在大肠杆菌中表达并纯化。用人类血清酶联免疫吸附测定法(ELISA)对所得抗原(C178)进行检测,以评估其诊断HCV的能力。ELISA结果显示,先前通过第三代酶免疫测定法(EIA)诊断为HCV阳性的患者血清中,92%含有针对C178抗原的抗体。用抗HCV阴性血清检测时,该抗原未出现假阳性结果。